China Botanic Pharmaceutical
eröffnet am 24.06.20 17:51:45 von
neuester Beitrag 21.04.23 13:12:23 von
neuester Beitrag 21.04.23 13:12:23 von
Beiträge: 18
ID: 1.326.796
ID: 1.326.796
Aufrufe heute: 0
Gesamt: 1.709
Gesamt: 1.709
Aktive User: 0
ISIN: US16890Y2037 · Symbol: FBDS
0,8777
USD
+5.317,90 %
+0,8615 USD
Letzter Kurs 02.05.24 Nasdaq OTC
Neuigkeiten
Werte aus der Branche Einzelhandel
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,8777 | +5.317,90 | |
| 2,5000 | +38,88 | |
| 0,5790 | +28,67 | |
| 7,4400 | +24,00 | |
| 6,5600 | +23,83 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 16,890 | -10,02 | |
| 0,62 | -11,43 | |
| 13,504 | -11,49 | |
| 13,060 | -15,14 | |
| 1,3900 | -21,47 |
Beitrag zu dieser Diskussion schreiben
Feedback
CEO Issamar Ginzberg beschreibt in einem Schreiben an die OTC Markets Group die Geschäftstätigkeit, die seit dem 1. März 2023 aufgenommen wurde: Financial Report / Supplemental Information
Die Website ist jetzt aktiv: https://www.fussbrands.com/
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights
https://www.wallstreet-online.de/nachricht/16157005-fuss-bra…
Die neue Homepage: https://fussbrand.com/ - leider noch "under construction".
reverse split 1 : 26
CBPI hat sich umbenannt in Fuss Brands Corp. (CBPID) und einen reverse split im Verhältnis 1 : 26 durchgeführt.Stichtag war der 22.7.2022.
Trading Spotlight
Quartalsbericht für das Quartel Oktober 21 - Januar 22
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&C…Man ist weiter auf der Suche nach einer Möglichkeit, die derzeit leere Firmenhülle mit einem Geschäft zu füllen, z.B. mittels einer Akquisition oder eines "reverse merger". Konkrete Zielunternehmen hat man aber noch nicht identifiziert.
Annual Report for the fiscal year ended October 31, 2021
https://www.sec.gov/ix?doc=/Archives/edgar/data/926844/00018…
China Botanic Pharmaceutical Inc.: Form-8K vom 24.8.2021
https://www.sec.gov/Archives/edgar/data/0000926844/000182912…
Am 24. August wurden 1 Million Aktien zum Preis von 250.000$ an Issamar Ginzberg, Israel Moshe Levy, Shmuel Rotbard, und Benjamin Levin verkauft. Die Käufer halten damit 96% an der Firma. Neuer CEO ist jetzt Issamar Ginzberg.
https://www.sec.gov/Archives/edgar/data/0000926844/000182912…
Am 24. August wurden 1 Million Aktien zum Preis von 250.000$ an Issamar Ginzberg, Israel Moshe Levy, Shmuel Rotbard, und Benjamin Levin verkauft. Die Käufer halten damit 96% an der Firma. Neuer CEO ist jetzt Issamar Ginzberg.
Nach 9 Jahren Abstinenz jetzt der erste Quartalsbericht: https://sec.report/Document/0001829126-21-006357/0001829126-…
Vielleicht kommt ja tatsächlich noch einmal Leben in die Bude.
On February 4, 2021 as a result of a custodianship in Clark County, Nevada, Case Number: A-20-827231-B Custodian Ventures LLC (“Custodian”) was appointed custodian of China Botanic Pharmaceutical, Inc. (the “Company”).
On February 4, 2021, Custodian appointed David Lazar as the Company’s Chief Executive Officer, President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors.
David Lazar, 30, is a private investor. Mr. Lazar has been a partner at Zenith Partners International since 2013, where he specializes in research and development, sales and marketing. From 2014 through 2015. Since February of 2018, Mr. Lazar has been the managing member of Custodian Ventures LLC, where he specializes in assisting distressed public companies. Since March 2018, David has acted as the managing member of Activist Investing LLC, which specializes in active investing in distressed public companies. David has a diverse knowledge of financial, legal and operations management; public company management, accounting, audit preparation, due diligence reviews and SEC regulations.
Quelle: https://sec.report/Document/0001213900-21-009951/
On February 4, 2021 as a result of a custodianship in Clark County, Nevada, Case Number: A-20-827231-B Custodian Ventures LLC (“Custodian”) was appointed custodian of China Botanic Pharmaceutical, Inc. (the “Company”).
On February 4, 2021, Custodian appointed David Lazar as the Company’s Chief Executive Officer, President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors.
David Lazar, 30, is a private investor. Mr. Lazar has been a partner at Zenith Partners International since 2013, where he specializes in research and development, sales and marketing. From 2014 through 2015. Since February of 2018, Mr. Lazar has been the managing member of Custodian Ventures LLC, where he specializes in assisting distressed public companies. Since March 2018, David has acted as the managing member of Activist Investing LLC, which specializes in active investing in distressed public companies. David has a diverse knowledge of financial, legal and operations management; public company management, accounting, audit preparation, due diligence reviews and SEC regulations.
Quelle: https://sec.report/Document/0001213900-21-009951/
Durchsuchen
